NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,264 | -2.7% | 3,959 | -3.6% | 0.32% | +2.9% |
| Q2 2023 | $414,336 | +6.0% | 4,106 | -3.3% | 0.31% | -1.3% |
| Q1 2023 | $390,816 | -28.2% | 4,248 | -29.2% | 0.32% | -40.6% |
| Q4 2022 | $544,592 | +5.7% | 6,003 | -11.4% | 0.53% | -5.9% |
| Q3 2022 | $515,000 | -10.1% | 6,776 | -0.0% | 0.56% | -0.2% |
| Q2 2022 | $573,000 | -12.0% | 6,778 | -8.7% | 0.56% | +9.1% |
| Q1 2022 | $651,000 | +31.0% | 7,424 | +30.6% | 0.52% | +45.2% |
| Q4 2021 | $497,000 | -23.2% | 5,685 | -28.2% | 0.36% | -31.1% |
| Q3 2021 | $647,000 | -15.6% | 7,914 | -5.9% | 0.52% | -11.8% |
| Q2 2021 | $767,000 | +7.3% | 8,411 | +0.5% | 0.59% | -5.8% |
| Q1 2021 | $715,000 | -2.6% | 8,370 | +7.7% | 0.62% | -7.3% |
| Q4 2020 | $734,000 | +50.1% | 7,773 | +38.1% | 0.67% | +57.5% |
| Q3 2020 | $489,000 | – | 5,629 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |